Tivic Health Systems (TIVC) Stock Price, News & Analysis

Company Overview

Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

Key Stats

• Today's Range: $3.90 to $4.09
• 50-Day Range: $3.71 to $7.12
• 52-Week Range: $2.43 to $16.08
• Volume: 18,947 shs
• Average Volume: 646,840 shs
• Market Capitalization: $3.45 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Tivic Health Systems Stock Analysis - MarketRank™

Tivic Health Systems scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Tivic Health Systems.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Tivic Health Systems has a P/B Ratio of 0.87. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.88% of the float of Tivic Health Systems has been sold short.

Short Interest Ratio / Days to Cover

Tivic Health Systems has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Tivic Health Systems has recently decreased by 13.02%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Tivic Health Systems does not currently pay a dividend.

Dividend Growth

Tivic Health Systems does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

3.88% of the float of Tivic Health Systems has been sold short.

Short Interest Ratio / Days to Cover

Tivic Health Systems has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Tivic Health Systems has recently decreased by 13.02%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.0 / 5
• News Sentiment: 0.53

News Sentiment

Tivic Health Systems has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.88 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Tivic Health Systems this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Tivic Health Systems insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.51% of the stock of Tivic Health Systems is held by insiders.

Percentage Held by Institutions

Only 4.25% of the stock of Tivic Health Systems is held by institutions.

TIVC Stock Analysis - Frequently Asked Questions

How have TIVC shares performed this year?

Tivic Health Systems' stock was trading at $5.8854 at the start of the year. Since then, TIVC stock has decreased by 32.9% and is now trading at $3.95.
View the best growth stocks for 2025 here.

How were Tivic Health Systems' earnings last quarter?

Tivic Health Systems, Inc. (NASDAQ:TIVC) released its earnings results on Thursday, May, 15th. The company reported ($2.52) EPS for the quarter. The company had revenue of $0.07 million for the quarter. Tivic Health Systems had a negative trailing twelve-month return on equity of 0.67% and a negative net margin of 4.07%.
Read the conference call transcript.

When did Tivic Health Systems' stock split?

Shares of Tivic Health Systems reverse split on the morning of Wednesday, August 23rd 2023.The 1-100 reverse split was announced on Wednesday, August 23rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, August 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

When did Tivic Health Systems IPO?

Tivic Health Systems (TIVC) raised $16 million in an initial public offering on Thursday, November 11th 2021. The company issued 3,000,000 shares at $5.00-$6.00 per share.

How do I buy shares of Tivic Health Systems?

Shares of TIVC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Tivic Health Systems own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Tivic Health Systems investors own include Meta Platforms (META), CrowdStrike (CRWD), Sunworks (SUNW), Applied DNA Sciences (APDN), Bionomics (BNOX), Cameco (CCJ) and BlackRock ESG Capital Allocation Term Trust (ECAT).

Company Calendar

• Last Earnings: 5/15/2025
• Today: 7/02/2025
• Next Earnings (Estimated): 8/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MEDICAL INFO SYS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:TIVC
• CIK: 1787740
• Web: www.tivichealth.com
• Phone: 888-276-6888
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: -4.07%
• Pretax Margin: -1,100.00%
• Return on Equity: -0.67%
• Return on Assets: -0.57%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.70
• Quick Ratio: 1.29

Sales & Book Value

• Annual Sales: $780 thousand
• Price / Sales: 4.46
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.55 per share
• Price / Book: 0.87

Miscellaneous

• Outstanding Shares: 880,000
• Free Float: 874,000
• Market Cap: $3.48 million
• Optionable: Not Optionable
• Beta: 1.99